1M
6M
1Y
3Y
5Y
All
| NAV: 30 Jul 2021 | ₹19.43 |
|---|---|
| Min. SIP Amount | ₹500 |
| Rating | 2star |
|---|---|
| Fund Size | ₹563.54 Cr |
Return calculator
Monthly SIP
One-Time
₹5,000 per month
Over the past
Total investment of ₹0
Would have become ₹0 (0.00%)
Returns and rankings
Category: Equity Sectoral / Thematic
Annualised returns
Absolute returns
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund returns | 44.4% | 28.3% | 13.9% | 12.6% |
| Category average | 58.4% | 28.2% | 13.5% | NA |
| Rank with in category | 6 | 4 | 2 | NA |
Understand termsinfo
Holdings (29)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 9.5% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 9.2% |
| Cipla Ltd. | Healthcare | Equity | 8.6% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 8.4% |
Divi's Laboratories Ltd. | Healthcare | Equity | 8.2% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 6.3% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 4.5% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 4.5% |
Fortis Healthcare Ltd. | Healthcare | Equity | 3.4% |
JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 3.0% |
See All
Pros and cons
Category: Equity Sectoral / Thematic
Pros
- 3Y Returns are higher than the category average returns
- 5Y Returns are higher than the category average returns
Cons
- Asset under management(AUM) is less than 500 Crs. Watch expense ratio when AUM is very low
- 1Y Returns are lower than the category average returns
Expense ratio, exit load and tax
Expense ratio: 1.11%
Inclusive of GST
Exit load
Exit load of 0.25% if redeemed within 30 days.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Understand termsinfo
Minimum investment amounts
| Min. for 1st investment | ₹1,000 |
| Min. for 2nd investment onwards | ₹5,000 |
| Min. for SIP | ₹500 |
Fund management
Sailesh Jain
Nov 2018 - Present
View Details
Rahul Singh
Apr 2020 - Present
View Details
Meeta Shetty
Nov 2018 - Present
View Details
Fund house & investment objective
Fund house contact details
Compare funds
Tata India Pharma & HealthCare Fund Direct Growth
VS
Add mutual fund to compare
